Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas.
Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas.
J Urol. 2017 Sep;198(3):644-649. doi: 10.1016/j.juro.2017.02.3341. Epub 2017 Mar 4.
We evaluated urinary incontinence outcomes following synthetic suburethral sling removal in women.
We reviewed a prospectively maintained database of 360 consecutive women who underwent transvaginal suburethral sling removal from 2005 to 2015. We excluded patients with neurogenic bladder, nonsynthetic or multiple slings, prior mesh for prolapse, concomitant surgery during sling excision, urethral erosion or fistula, postoperative retention or less than 6-month followup. Demographics, sling type, indications for removal, time to removal and patient reported outcomes were recorded. Outcomes were stratified by incontinence type, including stress predominant, urge predominant and mixed urinary incontinence. Subsequent management was evaluated, including observation, minimally invasive outpatient interventions (bulking agents, neuromodulation or onabotulinumtoxinA) or more invasive surgery (autologous fascial sling or bladder suspension). No patients elected to receive a subsequent synthetic sling. Success was defined by responses to UDI-6 (Urogenital Distress Inventory) questions 2 and 3, self-reported satisfaction with continence at the last visit and no further intervention.
Of the 99 patients who met inclusion criteria 27 denied any subjective leakage after suburethral sling removal alone while 72 experienced some degree of incontinence after removal. Stress predominant urinary incontinence occurred in 26 patients, which was persistent in 7 and de novo in 19, urge predominant incontinence was noted in 14, which was persistent in 6 and de novo in 8, and mixed urinary incontinence occurred in 32, which was persistent in 13 and de novo in 19. Mean followup was 23 months (range 6 to 114). The success rate following a single minimally invasive intervention after suburethral sling removal was 81%, 86% and 75% in patients with stress predominant, urge predominant and mixed urinary incontinence, respectively.
Patients who undergo suburethral sling removal may show urinary control, or de novo or persistent incontinence with a higher predilection for stress predominant or mixed urinary incontinence. However, after a single minimally invasive intervention following suburethral sling removal the success rate reached 75% to 86%.
我们评估了女性行合成尿道下吊带移除术后尿失禁的结局。
我们回顾性分析了 2005 年至 2015 年期间 360 例连续行经阴道尿道下吊带切除术患者的前瞻性数据库。我们排除了神经源性膀胱、非合成或多发性吊带、先前用于脱垂的网片、吊带切除术中同时进行的其他手术、尿道侵蚀或瘘管、术后留置或随访时间少于 6 个月的患者。记录患者的人口统计学、吊带类型、移除指征、移除时间和患者报告的结果。根据尿失禁类型对结果进行分层,包括压力性为主型、急迫性为主型和混合性尿失禁。评估后续治疗方法,包括观察、微创门诊干预(填充剂、神经调节或肉毒毒素 A)或更具侵袭性的手术(自体筋膜吊带或膀胱悬吊术)。没有患者选择接受后续合成吊带。成功定义为 UDI-6(尿失禁生活质量问卷)问题 2 和 3 的回答、末次就诊时对控尿的自我报告满意度和无进一步干预。
在符合纳入标准的 99 例患者中,27 例患者单独行尿道下吊带移除后否认有任何主观漏尿,而 72 例患者在移除后存在不同程度的尿失禁。26 例患者为压力性为主型尿失禁,其中 7 例持续存在,19 例为新发;14 例为急迫性为主型尿失禁,其中 6 例持续存在,8 例为新发;32 例为混合性尿失禁,其中 13 例持续存在,19 例为新发。平均随访时间为 23 个月(6~114 个月)。在压力性为主型、急迫性为主型和混合性尿失禁患者中,尿道下吊带移除后单次微创干预的成功率分别为 81%、86%和 75%。
行尿道下吊带移除术的患者可能会出现尿控,或新发或持续存在尿失禁,以压力性为主型或混合性尿失禁更为多见。然而,尿道下吊带移除后行单次微创干预,成功率可达 75%~86%。